Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 131,718 shares of KURA stock, worth $940,466. This represents 0.0% of its overall portfolio holdings.

Number of Shares

131,718

Previous 122,668 7.38%

Holding current value

$940,466

Previous $2.4 Million 52.13%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$8.51 - $19.21 $77,015 - $173,850	9,050 Added 7.38%	131,718 $1.15 Million
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $45,236 - $56,588	-2,436 Reduced 1.95%	122,668 $2.4 Million
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $673,818 - $883,305	38,438 Added 44.35%	125,104 $2.58 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $64,550 - $113,179	4,810 Added 5.88%	86,666 $1.85 Million
Q3 2023 Nov 13, 2023	BUY	$8.44 - $11.86 $353,526 - $496,779	41,887 Added 104.8%	81,856 $746,000
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $63,724 - $86,870	-5,950 Reduced 12.96%	39,969 $488,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $3.54 Million - $5.73 Million	-294,543 Reduced 86.51%	45,919 $627,000
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $107,838 - $184,564	-10,069 Reduced 2.87%	340,462 $6.24 Million
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $249,959 - $360,298	-21,219 Reduced 5.71%	350,531 $5.64 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $139,124 - $222,804	-11,385 Reduced 2.97%	371,750 $5.2 Million
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $146,921 - $206,948	-9,528 Reduced 2.43%	383,135 $7.18 Million
Q2 2021 Aug 16, 2021	BUY	$20.85 - $29.88 $1.93 Million - $2.77 Million	92,687 Added 30.9%	392,663 $8.19 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $1.01 Million - $1.59 Million	40,660 Added 15.68%	299,976 $8.48 Million
Q4 2020 Mar 01, 2021	BUY	$29.0 - $41.62 $6.4 Million - $9.18 Million	220,616 Added 570.07%	259,316 $8.47 Million
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $7,498 - $14,094	460 Added 1.2%	38,700 $1.19 Million
Q2 2020 Aug 14, 2020	BUY	$7.95 - $18.81 $180,655 - $427,438	22,724 Added 146.46%	38,240 $623,000
Q1 2020 May 15, 2020	SELL	$6.45 - $14.04 $53,386 - $116,209	-8,277 Reduced 34.79%	15,516 $154,000
Q4 2019 Feb 14, 2020	BUY	$12.97 - $15.94 $1,569 - $1,928	121 Added 0.51%	23,793 $327,000
Q3 2019 Nov 14, 2019	BUY	$14.75 - $20.87 $349,162 - $494,034	23,672 New	23,672 $359,000

Others Institutions Holding KURA

# of Institutions

193

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $478M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Kura Oncology, Inc. Transaction History